Berman, E., Shah, N. P., Deninger, M., Altman, J. K., Amaya, M., Begna, K., … Druker, B. (2024). CML and the WHO: Why? J Clin Oncol, 42(9), 984–986. https://doi.org/10.1200/JCO.23.01689

Berman, Ellin, Neil P. Shah, Michael Deninger, Jessica K. Altman, Maria Amaya, Kebede Begna, Ravi Bhatia, et al. “CML and the WHO: Why?” J Clin Oncol 42, no. 9 (March 20, 2024): 984–86. https://doi.org/10.1200/JCO.23.01689.

Berman E, Shah NP, Deninger M, Altman JK, Amaya M, Begna K, et al. CML and the WHO: Why? J Clin Oncol. 2024 Mar 20;42(9):984–6.

Berman, Ellin, et al. “CML and the WHO: Why?” J Clin Oncol, vol. 42, no. 9, Mar. 2024, pp. 984–86. Pubmed, doi:10.1200/JCO.23.01689.

Berman E, Shah NP, Deninger M, Altman JK, Amaya M, Begna K, Bhatia R, Chan O, Collins R, Curtin P, DeAngelo DJ, Drazer M, Maness L, Metheny L, Mohan S, Moore J, Oehler V, Pratz K, Pusic I, Rose M, Shomali W, Smith BD, Styler M, Sweet K, Talpaz M, Tanaka T, Tantravahi S, Tsai S, Vaughn J, Welborn J, Yang D, Mauro M, Cortes J, Radich J, Druker B. CML and the WHO: Why? J Clin Oncol. 2024 Mar 20;42(9):984–986.